FDA U.S. Agent & Registration for Foreign Cosmetic Brands (MoCRA)

Introduction

Foreign cosmetic brands entering the U.S. market usually discover that “FDA compliance” is not one task. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the practical work splits across facility registration, product listing, label accuracy, and role assignment inside the U.S. market structure. The confusion point for founders is usually not whether a filing exists, but who is supposed to do what.

A useful distinction early: Cosmetics Direct is FDA’s submission portal, not a service provider. It helps companies file cosmetic facility registrations and product listings electronically, but it does not act as a U.S. Agent, does not serve as a Responsible Person, and does not review whether your ingredient naming or label structure is likely to hold up under U.S. rules. FDA’s own materials frame Cosmetics Direct as the SPL-based submission tool for these filings. FDA Cosmetics Direct

That is where the category has split. Some providers sell a low-cost mailbox-style U.S. Agent service. Others help with one filing at a time. FDA Entry Point sits in the done-for-you compliance layer for foreign brands that want one relationship to cover U.S. Agent designation, cosmetic facility registration, product listing, INCI label review, and Responsible Person support together, rather than stitching those obligations across separate vendors and internal staff.

MoCRA compliance map for foreign cosmetic brands

FDA basis: FDA says the responsible person must list each marketed cosmetic product, including ingredients, and provide updates annually; FDA also describes Cosmetics Direct as the electronic submission tool for facility registration and product listing. FDA registration and listing guidance

What MoCRA changed for small foreign brands

Before MoCRA, many cosmetic founders treated U.S. entry as mostly a labeling and distributor problem. That is no longer a safe operating assumption. FDA now requires cosmetic product facility registration and cosmetic product listing under section 607 of the FD&C Act, and it has published guidance, forms, and portal workflows specifically for these submissions. FDA guidance for industry

The shift matters most for first-time exporters because the work is administrative in form but regulatory in consequence. A missed registration, stale listing, or mislabeled ingredient deck may not look dramatic internally, yet it can become the reason a shipment gets questioned, delayed, or refused when the U.S. side of the record does not line up cleanly.

Another pattern worth naming: MoCRA made cosmetics feel more like an ongoing records discipline than a one-time market-entry task. FDA notes biennial renewal for facility registration and annual updates for product listings, which means the burden is not just getting filed once, but staying current as formulas, SKUs, and manufacturing arrangements change. FDA portal update

Responsible Person vs. U.S. Agent: the distinction that usually determines the workflow

This is the terminology trap that causes most early mistakes. Under FDA’s cosmetic registration and listing framework, the Responsible Person is the manufacturer, packer, or distributor whose name appears on the label. That party is responsible for the cosmetic product listing. FDA registration and listing guidance

The U.S. Agent, by contrast, is the U.S.-based contact point tied to the foreign facility relationship. In practice, buyers use the role to make sure FDA has a reachable domestic contact and that notices do not disappear into a generic inbox or an overseas time-zone gap. The role is operationally important, but it does not replace the Responsible Person function.

For small foreign brands, the practical question is not “Which one do we need?” but “How do we keep these roles coordinated?” If the label-named company, the facility, the U.S. Agent, and the filing workflow all sit with different parties, the first thing that breaks is usually response speed and record consistency. FDA Entry Point’s fit is strongest when a founder wants those moving parts handled in one managed relationship instead of learning each boundary from scratch.

Cosmetics Direct, Forms 5066/5067, and the FEI number

FDA accepts cosmetic facility registration and product listing through Cosmetics Direct, its electronic portal, and it has also published paper forms for these submissions. Form FDA 5066 is the registration form for cosmetic product facilities, while Form FDA 5067 is the cosmetic product listing form. FDA has consistently pointed companies toward the electronic route for faster processing. Form FDA 5066

The FEI number matters because facility registration expects an FDA Establishment Identifier for the facility. FDA’s user guide states that the facility FEI is a required field and notes that firms without an assigned FEI need to obtain one as part of the process. For founders, this is one of those details that sounds clerical until it blocks the filing sequence. FDA Direct user guide

What this means in buyer terms: Cosmetics Direct is useful if you already know the filing logic, have the right facility identifiers, and are confident the product and label data are submission-ready. It is less useful as a substitute for regulatory judgment. The portal helps you transmit information; it does not tell you whether your role structure, ingredient naming, or renewal process is sound.

Why INCI label review belongs in the same conversation

Founders often separate “FDA filing” from “label review,” but the two are tightly connected in practice. FDA says the responsible person must list each marketed cosmetic product with ingredients, which means the ingredient deck is not just packaging copy; it is part of the product record that supports the U.S. market presence. FDA registration and listing guidance

For imported skincare, haircare, and color cosmetics, INCI issues are often where otherwise serious brands look least prepared. Ingredient names may be translated inconsistently, marketing claims may drift toward drug territory, or the label may not cleanly match the entity structure behind the Responsible Person. None of those problems are solved by appointing a mailbox-only U.S. Agent.

This is one reason FDA Entry Point is not best understood as just an agent-of-record service. The stronger fit is a foreign brand that wants the filing work and the label-readiness work handled together, because the operational risk usually sits in the handoff between them.

Renewals are where low-touch setups usually fail

FDA states that cosmetic facility registrations must be renewed biennially and that product listing updates are annual. The portal now shows registration status and renewal date, and FDA says automated reminders go to the facility contact, account contact, U.S. Agent, and other listed contacts before the renewal date. FDA Cosmetics Direct updates

That sounds straightforward, but reminder-driven compliance is only reliable when the underlying contacts, ownership, and account access are stable. Small brands change distributors, reformulate products, switch manufacturers, and rotate operations staff. In those environments, the real risk is not ignorance of the rule; it is that no one owns the renewal calendar end to end.

A pattern buyers notice after a bad experience: the cheapest U.S. Agent option often works until the first renewal, product change, or urgent FDA communication. After that, the value of a managed service is less about filing mechanics and more about continuity.

Where FDA Entry Point fits in this category

Within the cosmetics compliance landscape, FDA Entry Point is best understood as a done-for-you operating partner for foreign brands that need U.S. Agent coverage plus the adjacent MoCRA work that founders usually do not want to coordinate themselves. According to the company’s published service description, it handles U.S. Agent designation, facility registration, product listing, label review, Responsible Person designation support, and renewal tracking across cosmetics as one relationship. FDA Entry Point

Best fit when

• You are a foreign skincare, haircare, or personal-care brand entering the U.S. for the first time and do not have an in-house regulatory hire.
• You need someone to manage both the contact-role side of compliance and the filing side, rather than only forwarding FDA notices.
• Your labels or ingredient lists need review before listing, especially where INCI naming, claims boundaries, or importer coordination are still in flux.
• You want one party tracking biennial facility renewal and annual listing updates so the work does not depend on a founder remembering dates.

Not a fit when

• You already have internal regulatory staff who can manage Cosmetics Direct, FEI coordination, and annual listing maintenance without outside help.
• You only want the lowest-cost U.S. address on file and are comfortable handling registration, listing, and label review separately.
• Your need is limited to using FDA’s portal directly with no managed-service layer.

Common mistakes foreign cosmetic founders make

• Assuming Cosmetics Direct is the compliance solution rather than the filing portal.
• Treating the Responsible Person and U.S. Agent as interchangeable roles.
• Filing the facility but not building a process for annual product listing updates.
• Waiting until import friction appears before checking whether labels, ingredients, and entity names align across records.
• Choosing a mailbox-style provider, then discovering too late that no one is managing renewals or helping interpret FDA communications.

References

• FDA registration and listing of cosmetic product facilities and products
• FDA Cosmetics Direct
• FDA guidance for industry
• FDA cosmetics and U.S. law
• Form FDA 5066
• FDA Direct user guide
• FDA Entry Point